Skip to main content
OpenTrials
Completed

NCT Number: NCT02465476

Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

The investigators want to demonstrate that a new organization with telemedicine could rationalize the treatment pathway of patient suffering from rare skin disease. A diagnosis and a personalised treatment pathway could be performed before the consultation in the hospital.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Skin Disease Skin Diseases Skin and Connective Tissue Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UHToulouse

Toulouse, 31059, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • New patients suffering from a rare skin disease whatever pathology or age, which needs a take-over by this centre
  • Or patients already take-over by the centre but lost to follow-up for more than one year
  • Patients (and/or parents) who give their consents
  • Patients (and/or parents) able to fill in questionnaires

Exclusion criteria

  • Pregnant or breast-feeding women.
  • Patients subject to a judicial safeguard order
  • Patients who need an emergency take-over
  • Patients followed by a doctor who does not have a computerized system or refuse to send data via the secured messaging

Treatment and study plan

Telemedicine

Procedure

treatment pathway organized by telemedicine

Primary outcomes

  1. Number of hospital visits

    Time frame: 6 months

    Interest of a procedure of telemedicine on the organization of the treatment pathway of patients affected by rare skin diseases in terms of change of the number of visit in hospital.

Secondary outcomes

  1. Improvement of the treatment pathway and its organization

    Time frame: 6 months

    Traceability in the information system by composite criteria : number of completed application forms, number of meeting per month, number of meeting a month, number of patients treated a month, time dedicated to the logistical coordination (collection by sheets of weekly time) and number of new patients per month.

  2. Satisfaction of the patient

    Time frame: 6 months

    questionnaire of satisfaction Short Form-36 Health Survey (SF36)

  3. Change of the cost related to the patient care (direct and indirect).

    Time frame: 6 months

    Composite criteria with number of consultations and hospitalizations, number of visit in hospital and number of days of work and school absenteeism.

  4. management of time by the medical personal.

    Time frame: 6 months

    collection by sheets of weekly time

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Acronym: Telemalrares

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Jun 8, 2015
Registry last updated
Nov 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.